Global Pharma Rising Stars Outlook 2015

News provided by

Mar 05, 2015, 07:29 ET

DUBLIN, Mar. 05, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/5sqnn3/global_rising) has announced the addition of the "Global Rising Stars Outlook 2015" report to their offering.

Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets , approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space.

The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being added to it rapidly. As a result we have used some filters to select a few names for a detailed coverage in our Outlook this year.

Key Criteria for Our Selection are:

- Uniqueness of the Technology platform and the ability to scale up commercially in case of positive outcome of products in the pipeline
- Pipeline and clinical data analysis
- Marketed product and commercial tie up. Robustness of the Management, financial and business model.

Key Topics Covered:

Part 1- Rising Stars in Regenerative Medicine and Stem cell based Cell Therapies-Drugs of the Future

CESCA Therapeutics Inc. : Hedging the Risk with Stem Cell Based Devices and Therapies and Global Presence
Ocata Therapeutics Inc: Ophthalmic Focus- Macular degenerative conditions- Looking with a New Eye
Orgenesis: Focus- Diabetes- Tricking your Liver to Make Insulin!
Tigenix NV : Exploiting the Adipose Tissue- Multiple Applications of Fat?
Pluristem Therapeutics Inc: Regenerating and Recycling- Allogenic Therapies from the Placenta
Mesoblast: Leader in Regenerative Sapce in Korea- Focusing on International Markets
Medipost Co Ltd : Leader in Regenerative Space in Korea- Focusing on International Markets
JCR Pharmaceuticals co. Ltd.: First Stem Cell Based Product in Japan for Graft-Versus-Host Disease (GVHD).
Japan Tissue Engineering co. Ltd: Building Confidence in Regenerative Medicine- Fuji film Venture from Colors to Regenerative Medicine

Part II-Indian Innovators- Rising Stars:

Connexios: Maturing Pipeline and Focus on Diabetes/Metabolic Disorders to Drive Visibility
Cellworks : In silico Technology Platform Poised to Deliver- Focus on Personalised Medicine and Cancer
Bugworks: In silico Technology platform being applied to Serious Hospital Infections- Need of the hour!
Tergene : Affordable and Second Generation Vaccines- Addressing the Urgent needs of Emerging Markets.

Companies Mentioned

- Bugworks
- CESCA Therapeutics
- Cellworks
- Connexios
- JCR Pharmaceuticals
- Japan Tissue Engineering
- Medipost
- Mesobalst
- Mesobalst Ltd
- OCATA Therapeutics
- Orgenesis
- Pluristem Therapeutics
- Tergene
- TiGenix

For more information visit http://www.researchandmarkets.com/research/5sqnn3/global_rising